<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941006-1-00105</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> DATES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Written comments by December 20, 1994. The agency is proposing  <!-- PJG 0012 frnewline --> that any final rule that may be issued based upon this proposal  <!-- PJG 0012 frnewline --> become effective 180 days after its publication in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=4 --> Federal  <!-- PJG 0012 frnewline --> Register. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline --> <!-- PJG FTAG 4717 -->  <!-- PJG STAG 4717 -->  <!-- PJG ITAG l=01 g=1 f=3 --> Thursday <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=02 g=1 f=3 --> October 6, 1994 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=09 g=1 f=3 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=3 --> Part IV <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=04 g=1 f=3 --> Department of Health and Human Services <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=09 g=1 f=3 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=05 g=1 f=3 --> Food and Drug Administration <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=09 g=1 f=3 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=05 g=1 f=3 --> 21 CFR Part 101 et al. <!-- PJG 0012 frnewline --> Iron-Containing Supplements and Drugs; Label Warning Statements and Unit-Dose Packaging Requirements; Proposed Rule <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG -->  <!-- PJG /FTAG -->  <!-- PJG FTAG 4701 -->  <!-- PJG STAG 4701 -->  <!-- PJG ITAG l=90 g=1 f=3 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=90 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=90 g=1 f=1 --> &blank;/&blank;Vol. 59, No. 193&blank;/&blank;Thursday, October 6, 1994&blank;/&blank;Proposed Rules <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 -->  <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES </USDEPT>  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 --> 21 CFR Parts 101, 170, and 310  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=1 -->  <RINDOCK>[Docket Nos. 91P&hyph;0186 and 93P&hyph;0306] </RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> Iron-Containing Supplements and Drugs; Label Warning Statements  <!-- PJG 0012 frnewline --> and Unit-Dose Packaging Requirements  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Food and Drug Administration, HHS.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Proposed rule.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The Food and Drug Administration (FDA) is proposing  <!-- PJG 0012 frnewline --> regulations to require label warning statements for products  <!-- PJG 0012 frnewline --> taken in solid oral dosage form to supplement the dietary intake  <!-- PJG 0012 frnewline --> of iron or to provide iron for therapeutic purposes. FDA is also  <!-- PJG 0012 frnewline --> proposing regulations to require unit-dose packaging <FOOTCITE>1</FOOTCITE>  for iron-containing products that contain 30 milligrams (mg) or more of  <!-- PJG 0012 frnewline --> iron per dosage unit. <FOOTCITE>2</FOOTCITE>  FDA is proposing these regulations  <!-- PJG 0012 frnewline --> because of the acute iron poisonings, including deaths in  <!-- PJG 0012 frnewline --> children less than 6 years of age, attributable to accidental  <!-- PJG 0012 frnewline --> overdoses of iron-containing products. The intent of these  <!-- PJG 0012 frnewline --> proposed regulations is to reduce the risk of accidental iron poisonings of young children by utilizing FDA's authority in  <!-- PJG 0012 frnewline --> conjunction with the existing requirements of the U.S. Consumer  <!-- PJG 0012 frnewline --> Product Safety Commission (CPSC) for child-resistant packaging  <!-- PJG 0012 frnewline --> for household substances. This proposal responds to three  <!-- PJG 0012 frnewline --> citizen petitions (Docket Nos. 91P&hyph;0186/CP1, 93P&hyph;0306/CP1, and  <!-- PJG 0012 frnewline --> 93&hyph;0306/CP2) that requested that FDA take action to ensure that  <!-- PJG 0012 frnewline --> products containing iron or iron salts do not pose a health  <!-- PJG 0012 frnewline --> hazard to young children and infants.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <FOOTNOTE> <FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> 1 <!-- PJG /ITAG -->  </FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> For the purposes of this document ``unit-dose packaging'' means a method of packaging a product into a nonreusable container designed to hold a single dosage unit intended for administration directly from that container, irrespective of whether the recommended dose is one or more than one of these units. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FOOTNOTE>  <FOOTNOTE> <FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> 2 <!-- PJG /ITAG -->  </FOOTNAME> <!-- PJG ITAG l=28 g=1 f=1 --> In this document, the term ``dosage unit'' will be used to denote the individual physical units of the iron-containing product such as tablets, capsules, caplets, or other physical forms, irrespective of whether one or more than one of these physical units comprises the recommended dose. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </FOOTNOTE>  <!-- PJG /ITAG --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> DATES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Written comments by December 20, 1994. The agency is proposing  <!-- PJG 0012 frnewline --> that any final rule that may be issued based upon this proposal  <!-- PJG 0012 frnewline --> become effective 180 days after its publication in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=4 --> Federal  <!-- PJG 0012 frnewline --> Register. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline --> </DATE> <ADDRESS> <!-- PJG ITAG l=10 g=1 f=2 --> ADDRESSES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Submit written comments to the Dockets Management  <!-- PJG 0012 frnewline --> Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23, 12420  <!-- PJG 0012 frnewline --> Parklawn Dr., Rockville, MD 20857.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </ADDRESS> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  John N. Hathcock,  <!-- PJG 0012 frnewline -->  Center for Food Safety and Applied Nutrition (HFS&hyph;465),  <!-- PJG 0012 frnewline -->  Food and Drug Administration,  <!-- PJG 0012 frnewline -->  8301 Muirkirk Rd.,  <!-- PJG 0012 frnewline -->  Laurel, MD 20708,  <!-- PJG 0012 frnewline -->  301&hyph;594&hyph;6006.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FURTHER> <!-- PJG /STAG -->  <!-- PJG /FTAG --></p>
		</main>
</body></html>
            